Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer
Clinical trial NCT03734692 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03734692
- Sponsor
- Robert Edwards
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-28
- Primary completion
- 2024-07-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.